TRBV28
T cell receptor beta variable 28
Also known as: TCRBV28S1, TCRBV3S1, TVB28_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A0A5B6
- Gene
- TRBV28
- Ensembl
- ENSG00000211753
- Chromosome
- 7
- Canonical length
- 114 aa
- Protein class
- Predicted intracellular proteins, T-cell receptor genes
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Predicted to enable peptide antigen binding activity. Predicted to be involved in cell surface receptor signaling pathway. Predicted to be part of T cell receptor complex. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
114 residues, UniProt reviewed canonical sequence.
>A0A5B6|TRBV28
1 MGIRLLCRVA FCFLAVGLVD VKVTQSSRYL VKRTGEKVFL ECVQDMDHEN MFWYRQDPGL
61 GLRLIYFSYD VKMKEKGDIP EGYSVSREKK ERFSLILESA STNQTSMYLC ASSLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRBV28 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Highest tissue expression
- 185 nTPM
Expression across tissuesHPA
Tissue
- thymus: 185 nTPM
- tonsil: 32 nTPM
- lymph node: 23 nTPM
- spleen: 8.9 nTPM
- appendix: 8.7 nTPM
- urinary bladder: 4.9 nTPM
Single-cell type
- t-cells: 4.8 nCPM
- hematopoietic stem cells: 1.9 nCPM
- thymocytes: 1.7 nCPM
- early spermatids: 0.9 nCPM
- cdc: 0.1 nCPM
- innate lymphoid cells: 0.1 nCPM
Immune cell
- T-reg: 155 nTPM
- naive CD4 T-cell: 99 nTPM
- memory CD4 T-cell: 95 nTPM
- memory CD8 T-cell: 80 nTPM
- naive CD8 T-cell: 54 nTPM
- total PBMC: 34 nTPM
Brain region
- cerebellum: 0.7 nTPM
- basal ganglia: 0.6 nTPM
- cerebral cortex: 0.5 nTPM
- white matter: 0.4 nTPM
- medulla oblongata: 0.2 nTPM
- pons: 0.2 nTPM
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRBV28 as an antibody target. Whether an autoantibody or antibody against TRBV28 could matter depends on whether native TRBV28 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRBV28 is annotated at the cell surface, where native TRBV28 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TRBV28 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...